SUBSCRIBE
SUBSCRIBE

IPO

Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
As Market Froths, Blueprint Medicines Debuts $147 Million IPO for Massachusetts’ Biggest Recent IPO
April 30, 2015
 · 
4 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Aduro Biotech Launches $119 Million IPO with Hot Cancer Tech
April 15, 2015
 · 
5 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Deals
Rumors Prove True as SoCal’s aTyr Pharma Files for $86 Million IPO
April 7, 2015
 · 
5 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
IPOs Dropped 54 Percent in the First Quarter, As VC Investment Stays on the Sidelines
April 6, 2015
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
aTyr Pharma $76 Million Series E Gets IPO Rumors Flying
April 1, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
After Exiting RTP, CoLucid Pharma Files with SEC for $86M IPO
March 31, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Bone Repair Biotech PolyPid Ltd. Yanks $20M IPO As Selloff Continues
March 27, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
With Alexion Deal in Hand, Blueprint Medicines Preps for $100 Million IPO
March 24, 2015
 · 
4 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Juno Therapeutics Post IPO: Ups and Downs But Mostly Ups
March 17, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
San Diego’s Cidara Therapeutics Files for $69 Million IPO
March 16, 2015
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
HanchorBio Prices IPO at NT$120 Ahead of Innovation Board Listing on May 29
May 26, 2026
 · 
3 min read
Press Releases
Ingenia Therapeutics, a Clinical-Stage Biotechnology Company, Has Received Approval for an Initial Public Offering on the Korea Exchange (KRX)
May 22, 2026
 · 
6 min read
Press Releases
InMed Pharmaceuticals Amends Preferred Investment Options
May 19, 2026
 · 
1 min read
Press Releases
Mobia Medical Announces Pricing of Initial Public Offering
May 8, 2026
 · 
2 min read
Press Releases
Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering
May 8, 2026
 · 
4 min read
Press Releases
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 4, 2026
 · 
2 min read
Press Releases
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 4, 2026
 · 
2 min read
Press Releases
Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering
May 1, 2026
 · 
4 min read
Press Releases
Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering
May 1, 2026
 · 
4 min read
Press Releases
Avalyn Announces Pricing of Upsized Initial Public Offering
April 29, 2026
 · 
4 min read
Press Releases
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 21, 2026
 · 
2 min read
Press Releases
Kailera Therapeutics Announces Pricing of Initial Public Offering
April 17, 2026
 · 
2 min read
Press Releases
Integrant Awarded Nasdaq Ticker “INGT” Ahead of Highly Anticipated IPO
April 16, 2026
 · 
2 min read
Press Releases
Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies
April 10, 2026
 · 
5 min read
Press Releases
Diagens Biotechnology Raises US$101 Million in Hong Kong IPO; Shares More Than Double on First Day of Trading
March 31, 2026
 · 
3 min read
Press Releases
Theralase(R) Closes $1.1 M Non-Brokered Private Placement
March 10, 2026
 · 
1 min read
Press Releases
MiniMed announces pricing of initial public offering - March 5, 2026
March 5, 2026
 · 
5 min read
Press Releases
Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering
February 27, 2026
 · 
3 min read
Press Releases
MiniMed announces launch of IPO roadshow
February 24, 2026
 · 
6 min read
Press Releases
Agomab Announces Closing of Initial Public Offering
February 10, 2026
 · 
4 min read
Load More